免疫疗法相关的静血异常:出血和血栓并发症
Yingying Li1,2,3, Huiwen Jiang1,2,3, Lili Luo4,5,6
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Dadao, Wuhan, 430022, Hubei, China.
Annals of hematology
|July 1, 2025
概括
免疫疗法可能会导致严重的出血和凝血障碍. 本综述详细介绍了这些静血异常,它们的机制和管理策略,以获得更好的临床结果.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫疗法,包括免疫检查点抑制剂,抗体疗法和CAR-T细胞疗法,通过利用免疫系统有效向癌症.
- 然而,免疫疗法与严重的,危及生命的静血异常有关,影响患者的安全.
- 这些包括免疫性血小板缺血症,埃文斯综合征,血小板性血小板缺血性紫外线,获得的血友病A,血栓症,DIC和CAR-T相关的凝血病.
研究的目的:
- 为提供免疫治疗相关的静血异常的全面概述.
- 提高临床医生对其流行病学,临床表现,病理生理学和管理的理解.
- 在免疫疗法安全问题背景下指导治疗决策.
主要方法:
- 文献综述和对免疫疗法和静血性疾病现有研究的综合.
- 对流行病学数据,临床表现和拟议的病理生理机制的分析.
- 评估当前和新兴的治疗策略.
主要成果:
- 免疫疗法诱导的静血异常是由于过度的免疫激活,自身抗体的产生,以及炎症-凝血交叉.
- 病理生理机制尚未完全理解,缺乏标准化的管理.
- 这些并发症带来了重大的临床挑战,需要及时诊断和干预.
结论:
- 与免疫疗法相关的静血异常是一个关键的安全问题,需要提高临床意识.
- 对潜在机制的进一步研究对于开发标准化诊断和管理协议至关重要.
- 有效的管理策略对于优化癌症免疫治疗患者的结果至关重要.
相关概念视频
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
921
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
921
01:29Venous Thrombosis III: Interprofessional Care
27
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
27
01:30Venous Thrombosis IV: Nursing Management
27
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
27
01:05Introduction to Hemostasis
9.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.0K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
342
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
342